Diastolic heart failure: Diagnosis, therapy and impact of exercise training;Diastolische herzinsuffizienz: Diagnose, therapie und stellenwert von körperlichem training

Deutsche Zeitschrift fur Sportmedizin

Volumn 59, Issue 9, 2008, Pages 192-199

  Edelmann, F ^a   Pieske, Burkert ^a,b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Diastolic heart failure; Exercise training; Therapy

Indexed keywords

EID: 55749091470     PISSN: 03445925     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. PAULUS WJ, TSCHÖPE C, SANDERSON JE, RUSCONI C, FLACHSKAMPF FA, RADEMAKERS FE, MARINO P, SMISETH OA, DE KEULENAER G, LEITE-MOREIRA AF, BORBÉLY A, EDES I, HANDOKO ML, HEYMANS S, PEZZALI N, PIESKE B, DICKSTEIN K, FRASER AG, BRUTSAERT DL: How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 28 (2007) 2539-2550.
2. OWAN TE, HODGE DO, HERGES RM, JACOBSEN SJ, ROGER VL, REDFIELD MM: Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355 (2006) 251-259.
3. HOGG K, SWEDBERG K, MCMURRAY J: Heart failure with preserved left ventricular systolic function, epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol 43 (2004) 317-327.
4. REDFIELD MM, JACOBSEN SJ, BURNETT JC JR, MAHONEY DW, BAILEY KR, RODEHEFFER RJ: Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289 (2003) 194-202.
5. MCMURRAY JJ UND PFEFFER MA: Heart failure. Lancet 365 (2005) 1877-1889.
6. CLELAND JG, TENDERA M, ADAMUS J, FREEMANTLE N, POLONSKI L, TAYLOR J: PEP-CHF INVESTIGATORS: The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J27 (2006) 2338-2345.
7. BELLA JN, PALMIERI V, ROMAN MJ, LIU JE, WELTY TK, LEE ET, FABSITZ RR, HOWARD BV, DEVEREUX RB: Mitral ratio of peak early to late diastolic filling velocity as a predictor of mortality in middle-aged and elderly adults: the Strong Heart Study. Circulation 105 (2002) 1928-1933.
8. ZILE MR UND BRUTSAERT DL: New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment. Circulation 105 (2002) 1503-1508.
9. BHATIA RS, TU JV, LEE DS, AUSTIN PC, FANG J, HAOUZI A, GONG Y, LIU PP: Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 355 (2006) 260-269.
10. ANGEJA BG UND GROSSMAN W: Evaluation and management of diastolic heart failure. Circulation 107 (2003) 659-663.
11. WACHTER R, LÜERS C, KLETA S, GRIEBEL K, HERRMANN-LINGEN C, BINDER L, JANICKE N, WETZEL D, KOCHEN MM, PIESKE B: Impact of diabetes on left ventricular diastolic function in patients with arterial hypertension. Eur J Heart Fail 9 (2007) 469-476.
12. DE LAS FUENTES L, BROWN AL, MATHEWS SJ, WAGGONER AD, SOTO PF, GROPLER RJ, DÁVILA-ROMÁN VG: Metabolic syndrome is associated with abnormal left ventricular diastolic function independent of left ventricular mass. Eur Heart J 28 (2007) 553-559.
13. ZILE MR, BAICU CF, GAASCH WH: Diastolic heart failure- abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med 350 (2004) 1953-1959.
14. KITZMAN DW, HIGGINBOTHAM MB, COBB FR, SHEIKH KH, SULLIVAN MJ: Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism. J Am Coll Cardiol 17 (1991) 1065-1072.
15. HASENFUSS G UND PIESKE B: Calcium cycling in congestive heart failure. J Mol Cell Cardiol 34 (2002) 951-969.
16. BORBÉLY A, VAN DER VELDEN J, PAPP Z, BRONZWAER JG, EDES I, STIENEN GJ, PAULUS WJ: Cardiomyocyte stiffness in diastolic heart failure. Circulation 111 (2005) 774-781.
17. LAVIETES MH, GERULA CM, FLESS KG, CHERNIACK NS, ARORA RR: Inspiratory muscle weakness in diastolic dysfunction. Chest 126 (2004) 838-844.
18. KITZMAN DW, LITTLE WC, BRUBAKER PH, ANDERSON RT, HUNDLEY WG, MARBURGER CT, BROSNIHAN B, MORGAN TM, STEWART KP: Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 288 (2002) 2144-2150.
19. LIBONATI JR: Myocardial diastolic function and exercise. Med Sci Sports Exerc 31 (1999) 1741-1747.
20. SMART N, HALUSKA B, LEANO R, CASE C, MOTTRAM PM, MARWICK TH: Determinants of functional capacity in patients with chronic heart failure: role of filling pressure and systolic and diastolic function. Am Heart J 149 (2005) 152-158.
21. BRIGUORI C, BETOCCHI S, ROMANO M, MANGANELLI F, ANGELA LOSI M, CIAMPI Q, GOTTILLA R, LOMBARDI R, CONDORELLI M, CHIARIELLO M: Exercise capacity in hypertrophic cardiomyopathy depends on left ventricular diastolic function. Am J Cardiol 84 (1999) 9-15.
22. BURGESS MI, JENKINS C, SHARMAN JE, MARWICK TH: Diastolic stress echocardiography: hemodynamic validation and clinical significance of estimation of ventricular filling pressure with exercise. J Am Coll Cardiol 47 (2006)1891-900.
23. BAICU CF, ZILE MR, AURIGEMMA GP, GAASCH WH: Left ventricular systolic performance, function, and contractility in patients with diastolic heart failure. Circulation 111 (2005) 2306-2312.
24. YUSUF S, PFEFFER MA, SWEDBERG K, GRANGER CB, HELD P, MCMURRAY JJ, MICHELSON EL, OLOFSSON B, OSTERGREN J; CHARM INVESTIGATORS AND COMMITTEES: Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 362 (2003) 777-781.
25. KIRKPATRICK JN, VANNAN MA, NARULA J, LANG RM: Echocardiography in heart failure: applications, utility, and new horizons. J Am Coll Cardiol 50 (2007) 381-396.
26. HUNT SA, AMERICAN COLLEGE OF CARDIOLOGY: AMERICAN HEART ASSOCIATION TASK FORCE ON PRACTICE GUIDELINES (WRITING COMMITTEE TO UPDATE THE 2001 GUIDELINES FOR THE EVALUATION AND MANAGEMENT OF HEART FAILURE): ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 46 (2005) 1-82.
27. SWEDBERG K, CLELAND J, DARGIE H, DREXLER H, FOLLATH F, KOMAJDA M, TAVAZZI L, SMISETH OA, GAVAZZI A, HAVERICH A, HOES A, JAARSMA T, KOREWICKI J, LÉVY S, LINDE C, LOPEZ-SENDON JL, NIEMINEN MS, PIÉRARD L, REMME WJ; TASK FORCE FOR THE DIAGNOSIS AND TREATMENT OF CHRONIC HEART FAILURE OF THE EUROPEAN SOCIETY OF CARDIOLOGY: Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26 (2005) 1115-1140.
28. ZIEMAN SJ, KASS DA: Advanced glycation endproduct crosslinking in the cardiovascular system: potential therapeutic target for cardiovascular disease. Drugs 64 (2004) 459-470.
29. ARIAS MA, GARCÍA-RÍO F, ALONSO-FERNÁNDEZ A, MEDIANO O, MARTÍNEZ I, VILLAMOR J: Obstructive sleep apnea syndrome affects left ventricular diastolic function: effects of nasal continuous positive airway pressure in men. Circulation 112 (2005) 375-383.
30. VERDECCHIA P, SCHILLACI G, BORGIONI C, CIUCCI A, GATTOBIGIO R, ZAMPI I, REBOLDI G, PORCELLATI C: Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation 97 (1998) 48-54.
31. KLINGBEIL AU, SCHNEIDER M, MARTUS P, MESSERLI FH, SCHMIEDER RE: A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. Am J Med 115 (2003) 41-46.
32. DEVEREUX RB, DAHLÖF B, GERDTS E, BOMAN K, NIEMINEN MS, PAPADEMETRIOU V, ROKKEDAL J, HARRIS KE, EDELMAN JM, WACHTELL K: Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial. Circulation 110 (2004) 1456-1462.
33. WARNER JG JR, METZGER DC, KITZMAN DW, WESLEY DJ, LITTLE WC: Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise. J Am Coll Cardiol 33 (1999) 1567-1572.
34. SUETA CA, RUSSO A, SCHENCK A, BROWN DW, SIMPSON RJ: Effect of angiotensin-converting inhibitor or angiotensin receptor blocker on one-year survival in patients >or=65 years hospitalized with a left ventricular ejection fraction >or=50%. Am J Cardiol 91 (2003) 363-365.
35. BERGSTRÖM A, ANDERSSON B, EDNER M, NYLANDER E, PERSSON H, DAHLSTRÖM U: Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC). Eur J Heart Fail 6 (2004) 453-461.
36. WILLIAMS B, LACY PS, THOM SM, CRUICKSHANK K, STANTON A, COLLIER D, HUGHES AD, THURSTON H, O'ROURKE M; CAFE INVESTIGATORS; ANGLO-SCANDINAVIAN CARDIAC OUTCOMES TRIAL INVESTIGATORS; CAFE STEERING COMMITTEE AND WRITING COMMITTEE: Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 113 (2006) 1213-1225.
37. SETARO JF, ZARET BL, SCHULMAN DS, BLACK HR, SOUFER R: Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance. Am J Cardiol 66 (1990) 981-986.
38. ZANNAD F, ALLA F, DOUSSET B, PEREZ A, PITT B: Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators. Circulation 102 (2000) 2700-2706.
39. WITTE KK, NIKITIN NP, CLELAND JG, CLARK AL: Excessive breathlessness in patients with diastolic heart failure. Heart 92 (2006) 1425-1429.
40. CARUANA L, PETRIE MC, DAVIE AP, MCMURRAY JJ: Do patients with suspected heart failure and preserved left ventricular systolic function suffer from "diastolic heart failure" or from misdiagnosis? A prospective descriptive study. BMJ 321 (2000) 215-218.
41. BELARDINELLI R, GEORGIOU D, CIANCI G, PURCARO A: Randomized, controlled trial of long-term moderate exercise training in chronic heart failure: effects on functional capacity, quality of life, and clinical outcome. Circulation 99 (1999) 1173-1182.
42. WISLØFF U, STØYLEN A, LOENNECHEN JP, BRUVOLD M, ROGNMO Ø, HARAM PM, TJØNNA AE, HELGERUD J, SLØRDAHL SA, LEE SJ, VIDEM V, BYE A, SMITH GL, NAJJAR SM, ELLINGSEN Ø, SKJAERPE T: Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study. Circulation 115 (2007) 3086-3094.
43. LINKE A, ADAMS V, SCHULZE PC, ERBS S, GIELEN S, FIEHN E, MÖBIUS-WINKLER S, SCHUBERT A, SCHULER G, HAMBRECHT R: Antioxidative effects of exercise training in patients with chronic heart failure: increase in radical scavenger enzyme activity in skeletal muscle. Circulation 111 (2005) 1763-1770.
44. CONRAADS VM, BECKERS P, VAES J, MARTIN M, VAN HOOF V, DE MAEYER C, POSSEMIERS N, WUYTS FL, VRINTS CJ: Combined endurance/resistance training reduces NT-proBNP levels in patients with chronic heart failure. Eur Heart J 25 (2004) 1797-1805.
45. ARBAB-ZADEH A, DIJK E, PRASAD A, FU Q, TORRES P, ZHANG R, THOMAS JD, PALMER D, LEVINE BD: Effect of aging and physical activity on left ventricular compliance. Circulation 110 (2004) 1799-1805.
46. GARY RA, SUETA CA, DOUGHERTY M, ROSENBERG B, CHEEK D, PREISSER J, NEELON V, MCMURRAY R: Home-based exercise improves functional performance and quality of life in women with diastolic heart failure. Heart Lung 33 (2004) 210-218.
47. SMART N, HALUSKA B, JEFFRIESS L, MARWICK TH: Exercise training in systolic and diastolic dysfunction: effects on cardiac function, functional capacity, and quality of life. Am Heart J 153 (2007) 530-536.